New tool to help lung cancer patients understand their illness better

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates a novel screening tool designed to assess the information needs, preferences, and understanding of patients with metastatic or incurable lung cancer. The study compares the effectiveness of this tool against usual care in improving patients' comprehension of their illness and prognosis. By facilitating more frequent discussions about disease status and treatment goals, the trial aims to align medical care with patients' values and preferences. Participants will be monitored over a three-month period to measure changes in their perception of curability.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Within 3 months of biopsy-confirmed diagnosis of stage IV lung cancer
* Age 18 or over
* English speaking
* Attending a follow-up visit at the thoracic medical oncology clinic
* Plans to receive or actively undergoing cancer-directed systemic treatment at MD Anderson

Exclusion Criteria:

• Diagnosis of cognitive impairment or dementia requiring a surrogate decision maker

Where it's running

• MD Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Kayley Ancy, MD — M.D. Anderson Cancer Center
• Study coordinator: Kayley M Ancy, MD
• Email: kmclemings@mdanderson.org
• Phone: 832-729-1621

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Monitoring T Cell Responses in Cancer Patients Receiving Anti-PD-1 Therapy

  This study is trying to see how T cells in the blood can help doctors understand how well anti-PD-1 therapy works for people with melanoma, lung cancer, and other cancers.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT06075524

• Using electric fields to treat spinal cancer spread in breast cancer patients

  This study tests if wearing a portable device that uses electric fields can help breast cancer patients whose cancer has spread to the spine feel better and slow down tumor growth.

  Recruiting Mayo Clinic · Jacksonville, Florida · NCT05746325

• Using a special dye to detect lung cancer during surgery

  This study is testing a special dye to see if it can help doctors find lung cancer more easily during surgery.

  Recruiting Phase 1/2 Stanford University · Palo Alto, California · NCT03582124

• Understand cancer cachexia subtypes in advanced cancers

  This study tests how cancer cachexia presents in people with advanced colorectal, pancreatic, or lung cancer to see if different subtypes relate to outcomes.

  Recruiting Kaiser Permanente · Pleasanton, California · NCT07776353

• Couples Coping Together Against Cancer: A Feasibility and Acceptability Look

  This observational study tests whether a brokered program for patients with cancer and their partners is feasible and acceptable, and whether it may reduce distress over time.

  Recruiting City of Hope Medical Center · Duarte, California · NCT07664579

• 64Cu-DOTA-Pembrolizumab PET to See If Treatment Is Working in Stage IV NSCLC

  This study tests a new PET imaging agent paired with pembrolizumab to see if it can show which tumors are still responding in adults with stage IV NSCLC who are already receiving pembrolizumab.

  Recruiting Phase 1 City of Hope Medical Center · Duarte, California · NCT07619599

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.